RNF213 Acts as a Molecular Switch for Cav-1 Ubiquitination and Phosphorylation in Human Cells
Jungmi Choi(Kyoto University), Shohab Youssefian(Kyoto University), Ryoichi Inoue(Kyoto University), Hatasu Kobayashi(Kyoto University), Kazuhiro Sonomura(Kyoto University), Tohru Tezuka(Kyoto University), Yohei Mineharu(University of Michigan), Yukiko Shimizu(Kyoto University), Minsoo Kim(Kyoto University), Akio Koizumi(Kyoto University), Yuki Masuo(Kyoto University), Kouji H. Harada(Kyoto University)
Cited by 6
Related Papers
Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development
|PLoS ONE|2011|711
Dwarfing genes in wheat
|Elsevier eBooks|1985|371
Expression of the gene for a small GTP binding protein in transgenic tobacco elevates endogenous cytokinin levels, abnormally induces salicylic acid in response to wounding, and increases resistance to tobacco mosaic virus infection.
|Proceedings of the National Academy of Sciences|1994|163
Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo
|Journal of the American Heart Association|2015|159